肝硬化合并上消化道出血应用奥曲肽联合凝血酶治疗的疗效及再出血率分析

目的:探究肝硬化合并上消化道出血应用奥曲肽联合凝血酶治疗效果以及再出血率情况。方法:选取本院收治的80例肝硬化合并上消化道出血患者进行研究,收集时间为2017年1月到2018年1月,将其按照不同的治疗方法作为分组原则,分为对照组(40例)、观察组(40例)。对照组患者给予奥曲肽,观察组在对照组的基础上给予凝血酶进行治疗,对比2组肝硬化合并上消化道出血患者的治疗效果以及再出血发生率。结果:观察组患者总有效率、再出血率与对照组相比差异性较大:P<0.05。观察组患者止血效果更佳:P<0.05。结论:对肝硬化合并上消化道出血患者应用奥曲肽、凝血酶进行治疗效果显著,值得广泛应用。

To explore the effect of octreotide combined with thrombin and the rate of rebleeding in patients with cirrhosis and upper gastrointestinal bleeding.Methods:80 cases of liver cirrhosis with upper gastrointestinal bleeding were studied in our hospital from January 2017 to January 2018.They were divided into the control group(40 cases)and the observation group(40 cases)according to the different treatment methods.The patients in the control group were given octreotide,and the observation group was treated with thrombin on the basis of the control group.The treatment effect and the rate of rebleeding were compared between the 2 groups of liver cirrhosis with upper gastrointestinal bleeding.Results:the total effective rate and rebleeding rate in the observation group were significantly different from those in the control group:P<0.05.The hemostatic effect of the patients in the observation group was better:P<0.05.Conclusion:the application of octreotide and thrombin in patients with cirrhosis and upper gastrointestinal bleeding is effective and worthy of wide application.